Riverside Partners, a private equity firm focused on investing in middle market healthcare and technology companies, has closed its Fund V at $561m.
Riverside Fund V, which follows the firm’s $406m Riverside Fund IV, has received significant support from existing investors.
Founded in 1989 and led by General Partner David Belluck, Riverside Partners focuses on investing in companies with revenues between $20 -$200m and with $5 – $25m of EBITDA.
FinSMEs
14/05/2012